• Thurs news: Novartis not joining weight loss race. Pharma marketing and climate change. Roche flu treatment trial. Cercle’s fund raise for women’s health. ICER looks at GSK COPD drugs. See more on our front page

Roche Doubles Down on Jnana's RAPID Platform in $2B Deal (Updated)

cafead

Administrator
Staff member
  • cafead   Nov 16, 2022 at 10:32: AM
via It's been a lucrative Tuesday for Jnana Therapeutics which forged a second small molecule discovery and development collaboration and licensing agreement with Roche valued at up to $2 billion.

article source
 

<